REHAM GHALI: Open Payments
NPI 1639618226 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,467 in 130 payments from 27 companies in 2025. Trend: 2023 $1,824 · 2024 $2,053 · 2025 $9,467
Honoraria: $5,375Food & beverage: $3,196Travel & lodging: $895
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 21 | $6,987 |
| ABBVIE INC. | 45 | $801 |
| Lundbeck LLC | 11 | $273 |
| ARGENX US, INC. | 2 | $230 |
| UCB, Inc. | 6 | $226 |
| Eisai Inc. | 6 | $172 |
| Novartis Pharmaceuticals Corporation | 6 | $112 |
| PFIZER INC. | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
Products named: Symbravo, QULIPTA, UBRELVY, VYEPTI, VYVGART, Fintepla, KESIMPTA, Leqembi.
Industry payments across NC — which companies pay providers there.
